Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia

Hematology Journal

Volumn 5, Issue 6, 2004, Pages 528-529

  Ramachandran, Akila ^a   Majumdar, Gautam ^a  

^a DONCASTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

CLL; Fludarabine; TLS

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUDARABINE; HEMOGLOBIN; PREDNISOLONE;

ACUTE DISEASE; ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; DRUG INTERMITTENT THERAPY; HEMOGLOBIN DETERMINATION; HUMAN; MALE; SPLENOMEGALY; TUMOR LYSIS SYNDROME;

ADMINISTRATION, ORAL; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; TUMOR LYSIS SYNDROME; VIDARABINE;

EID: 11044222289     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200409     Document Type: Article

References (3)

1. Hussain K, Mazza J J, Clouse L H. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. Am J Hematol 2003; 72: 212-215.
2. Jensen M, Winkler U, Manzke O, Diehl V, Engert A. Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol 1998; 77: 89-91.
3. Cheson B D, Frame J N, Vena D, Quashu N, Sorensen J M. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia. J Clin Oncol 1998; 16: 2313-2320.